# AbbVie id: ent_abbvie wikidata: Q14662364 kind: organization timeline: /timelines/abbvie.md page: /record/abbvie same_as: https://asof.is/record/abbvie (how to cite the id: /identifiers.md) AbbVie is a pharmaceutical company, headquartered in North Chicago. It reported revenue of $61.16B for the period ended December 31, 2025. ## Key facts - Headquarters: North Chicago · claim: /claim/clm_E74DBC8CCF1E.md - Revenue: $61.16B (to 2025-12-31) [recorded: 61,160,000,000 United States dollar] · claim: /claim/clm_4A7BE8ED0078.md - Ticker: ABBV · NYSE · claim: /claim/clm_B87EDEAECF6B.md ## Questions **Where is AbbVie headquartered?** North Chicago. **What is AbbVie's revenue?** $61.16B for the period ended December 31, 2025. ## Fact pages One page per fact: the current value with its sources, then every dated value and what replaced what. Fetch any of them as markdown. - [AbbVie headquarters](/record/abbvie/headquarters.md) - [AbbVie revenue](/record/abbvie/revenue.md) - [AbbVie net income](/record/abbvie/net_income.md) - [AbbVie operating income](/record/abbvie/operating_income.md) - [AbbVie quarterly revenue](/record/abbvie/quarterly_revenue.md) ## Current state What the record asserts: claims that held, valid by their sources or primary-sourced at confidence 0.7 or more. Unverified, disputed, retracted and review-marked claims are listed below, labelled, not here. - [AbbVie](/record/abbvie.md) | registrant_name | AbbVie Inc. | valid undated to present | conf 0.95 | valid | [clm_78F47A4D8706](/claim/clm_78F47A4D8706.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | headquarters | North Chicago | valid undated to present | conf 0.95 | valid | [clm_E74DBC8CCF1E](/claim/clm_E74DBC8CCF1E.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | revenue | 61,160,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,226,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 15,075,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 147,680,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_0DE2793ECF77](/claim/clm_0DE2793ECF77.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | listed_on | NYSE | valid undated to present | conf 0.95 | valid | [clm_BBC331549951](/claim/clm_BBC331549951.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 10,774,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_A17F69D94691](/claim/clm_A17F69D94691.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 4,218,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_B8246C4E0E64](/claim/clm_B8246C4E0E64.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 6,267,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5AF8A08D6F94](/claim/clm_5AF8A08D6F94.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 17,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DA52AAE1BFB4](/claim/clm_DA52AAE1BFB4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,616,306 shares | valid 2026-10-26 to present | conf 0.95 | valid | [clm_54135339A00E](/claim/clm_54135339A00E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -4,583,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_FA883B408C6E](/claim/clm_FA883B408C6E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm ## All claims One claim per line, newest first. Superseded claims stay visible. - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,616,306 shares | valid 2026-10-26 to present | conf 0.95 | valid | [clm_54135339A00E](/claim/clm_54135339A00E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 147,680,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_0DE2793ECF77](/claim/clm_0DE2793ECF77.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 6,267,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5AF8A08D6F94](/claim/clm_5AF8A08D6F94.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 10,774,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_A17F69D94691](/claim/clm_A17F69D94691.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 4,218,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_B8246C4E0E64](/claim/clm_B8246C4E0E64.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 17,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DA52AAE1BFB4](/claim/clm_DA52AAE1BFB4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -4,583,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_FA883B408C6E](/claim/clm_FA883B408C6E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,117,285 shares | valid 2026-07-27 to 2026-10-26 | conf 0.95 | superseded | superseded_by [clm_54135339A00E](/claim/clm_54135339A00E.md) | [clm_86C65743AE05](/claim/clm_86C65743AE05.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -5,935,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_FA883B408C6E](/claim/clm_FA883B408C6E.md) | [clm_00E837EDC859](/claim/clm_00E837EDC859.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,569,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_A17F69D94691](/claim/clm_A17F69D94691.md) | [clm_2B61F63D78FE](/claim/clm_2B61F63D78FE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 6,432,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_5AF8A08D6F94](/claim/clm_5AF8A08D6F94.md) | [clm_67BFBB091A03](/claim/clm_67BFBB091A03.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 3,613,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_B8246C4E0E64](/claim/clm_B8246C4E0E64.md) | [clm_A0327C4F8772](/claim/clm_A0327C4F8772.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 135,115,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_0DE2793ECF77](/claim/clm_0DE2793ECF77.md) | [clm_A320A5717609](/claim/clm_A320A5717609.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 16,990,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_DA52AAE1BFB4](/claim/clm_DA52AAE1BFB4.md) | [clm_E6270C8DB4ED](/claim/clm_E6270C8DB4ED.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,766,792,821 shares | valid 2026-04-28 to 2026-07-27 | conf 0.95 | superseded | superseded_by [clm_86C65743AE05](/claim/clm_86C65743AE05.md) | [clm_7C1384CB0CC0](/claim/clm_7C1384CB0CC0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 15,002,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_E6270C8DB4ED](/claim/clm_E6270C8DB4ED.md) | [clm_2A1D46B6132E](/claim/clm_2A1D46B6132E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,990,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_67BFBB091A03](/claim/clm_67BFBB091A03.md) | [clm_78F42A193166](/claim/clm_78F42A193166.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -6,656,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_00E837EDC859](/claim/clm_00E837EDC859.md) | [clm_86F602E30464](/claim/clm_86F602E30464.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 695,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_A0327C4F8772](/claim/clm_A0327C4F8772.md) | [clm_879DEDC1ACEA](/claim/clm_879DEDC1ACEA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 136,463,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_A320A5717609](/claim/clm_A320A5717609.md) | [clm_CD090548C18D](/claim/clm_CD090548C18D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,391,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_2B61F63D78FE](/claim/clm_2B61F63D78FE.md) | [clm_E7E1876E4E88](/claim/clm_E7E1876E4E88.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/0001551152-26-000017-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,768,169,012 shares | valid 2026-02-10 to 2026-04-28 | conf 0.95 | superseded | superseded_by [clm_7C1384CB0CC0](/claim/clm_7C1384CB0CC0.md) | [clm_F33386E6A71F](/claim/clm_F33386E6A71F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,226,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 61,160,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -3,270,000,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_86F602E30464](/claim/clm_86F602E30464.md) | [clm_6A970AB08DB3](/claim/clm_6A970AB08DB3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 133,960,000,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_CD090548C18D](/claim/clm_CD090548C18D.md) | [clm_BAF68C4E73F9](/claim/clm_BAF68C4E73F9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 15,075,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,229,000,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_E7E1876E4E88](/claim/clm_E7E1876E4E88.md) | [clm_F526599F9FFE](/claim/clm_F526599F9FFE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,384,632 shares | valid 2025-10-27 to 2026-02-10 | conf 0.95 | superseded | superseded_by [clm_F33386E6A71F](/claim/clm_F33386E6A71F.md) | [clm_A66CE3EA88E8](/claim/clm_A66CE3EA88E8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 186,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_879DEDC1ACEA](/claim/clm_879DEDC1ACEA.md) | [clm_48C26099DBC0](/claim/clm_48C26099DBC0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 15,776,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_2A1D46B6132E](/claim/clm_2A1D46B6132E.md) | [clm_7673BF825A9D](/claim/clm_7673BF825A9D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,904,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_78F42A193166](/claim/clm_78F42A193166.md) | [clm_8A7602897846](/claim/clm_8A7602897846.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 133,898,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_BAF68C4E73F9](/claim/clm_BAF68C4E73F9.md) | [clm_9AD5C074902A](/claim/clm_9AD5C074902A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,629,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_F526599F9FFE](/claim/clm_F526599F9FFE.md) | [clm_E498EA77B417](/claim/clm_E498EA77B417.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -2,642,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_6A970AB08DB3](/claim/clm_6A970AB08DB3.md) | [clm_E6BEEAB8A7CC](/claim/clm_E6BEEAB8A7CC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,766,558,253 shares | valid 2025-07-29 to 2025-10-27 | conf 0.95 | superseded | superseded_by [clm_A66CE3EA88E8](/claim/clm_A66CE3EA88E8.md) | [clm_AAA173651D55](/claim/clm_AAA173651D55.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,467,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_E498EA77B417](/claim/clm_E498EA77B417.md) | [clm_6EBD1BCE1675](/claim/clm_6EBD1BCE1675.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 15,423,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_7673BF825A9D](/claim/clm_7673BF825A9D.md) | [clm_83F895DA4455](/claim/clm_83F895DA4455.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,894,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_8A7602897846](/claim/clm_8A7602897846.md) | [clm_BA8EDB44AFDD](/claim/clm_BA8EDB44AFDD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -183,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_E6BEEAB8A7CC](/claim/clm_E6BEEAB8A7CC.md) | [clm_BAE788922C38](/claim/clm_BAE788922C38.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 938,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_48C26099DBC0](/claim/clm_48C26099DBC0.md) | [clm_BC27B55DAB48](/claim/clm_BC27B55DAB48.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 137,182,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_9AD5C074902A](/claim/clm_9AD5C074902A.md) | [clm_E991D9CEB134](/claim/clm_E991D9CEB134.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,766,403,027 shares | valid 2025-04-30 to 2025-07-29 | conf 0.95 | superseded | superseded_by [clm_AAA173651D55](/claim/clm_AAA173651D55.md) | [clm_4E3C69CACDA8](/claim/clm_4E3C69CACDA8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 1,420,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_BAE788922C38](/claim/clm_BAE788922C38.md) | [clm_1A40CEC7F75A](/claim/clm_1A40CEC7F75A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,175,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_6EBD1BCE1675](/claim/clm_6EBD1BCE1675.md) | [clm_213E56FCF1C0](/claim/clm_213E56FCF1C0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,286,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_BC27B55DAB48](/claim/clm_BC27B55DAB48.md) | [clm_7C59982F22F4](/claim/clm_7C59982F22F4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 13,343,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_83F895DA4455](/claim/clm_83F895DA4455.md) | [clm_8213D3858DF4](/claim/clm_8213D3858DF4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,733,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_BA8EDB44AFDD](/claim/clm_BA8EDB44AFDD.md) | [clm_837AACDD66BC](/claim/clm_837AACDD66BC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 136,165,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_E991D9CEB134](/claim/clm_E991D9CEB134.md) | [clm_E8E57D49C82F](/claim/clm_E8E57D49C82F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,765,354,859 shares | valid 2025-01-31 to 2025-04-30 | conf 0.95 | superseded | superseded_by [clm_4E3C69CACDA8](/claim/clm_4E3C69CACDA8.md) | [clm_577B3A94C3B3](/claim/clm_577B3A94C3B3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 135,161,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_E8E57D49C82F](/claim/clm_E8E57D49C82F.md) | [clm_1A98128E2186](/claim/clm_1A98128E2186.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,524,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_213E56FCF1C0](/claim/clm_213E56FCF1C0.md) | [clm_42142B046C44](/claim/clm_42142B046C44.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,278,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) | [clm_4595D4B200E2](/claim/clm_4595D4B200E2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | revenue | 56,334,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) | [clm_46C087CADCC6](/claim/clm_46C087CADCC6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 9,137,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) | [clm_7198B453007F](/claim/clm_7198B453007F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 3,325,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_1A40CEC7F75A](/claim/clm_1A40CEC7F75A.md) | [clm_A7EA278F1A95](/claim/clm_A7EA278F1A95.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,140,323 shares | valid 2024-10-28 to 2025-01-31 | conf 0.95 | superseded | superseded_by [clm_577B3A94C3B3](/claim/clm_577B3A94C3B3.md) | [clm_633C3749CF8B](/claim/clm_633C3749CF8B.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 143,422,000,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_1A98128E2186](/claim/clm_1A98128E2186.md) | [clm_114245DEFEF9](/claim/clm_114245DEFEF9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 6,032,000,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_A7EA278F1A95](/claim/clm_A7EA278F1A95.md) | [clm_15A624C68E3C](/claim/clm_15A624C68E3C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 14,460,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_8213D3858DF4](/claim/clm_8213D3858DF4.md) | [clm_1DE14AF1FBB3](/claim/clm_1DE14AF1FBB3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,561,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_7C59982F22F4](/claim/clm_7C59982F22F4.md) | [clm_930D6A477C14](/claim/clm_930D6A477C14.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,257,000,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_42142B046C44](/claim/clm_42142B046C44.md) | [clm_A6BEF465151C](/claim/clm_A6BEF465151C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,831,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_837AACDD66BC](/claim/clm_837AACDD66BC.md) | [clm_C42D4D3906A5](/claim/clm_C42D4D3906A5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,766,343,745 shares | valid 2024-07-29 to 2024-10-28 | conf 0.95 | superseded | superseded_by [clm_633C3749CF8B](/claim/clm_633C3749CF8B.md) | [clm_EF2804D82FE5](/claim/clm_EF2804D82FE5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,370,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_930D6A477C14](/claim/clm_930D6A477C14.md) | [clm_1CC594D9C4F0](/claim/clm_1CC594D9C4F0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 6,778,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_15A624C68E3C](/claim/clm_15A624C68E3C.md) | [clm_44F4EB401556](/claim/clm_44F4EB401556.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 141,937,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_114245DEFEF9](/claim/clm_114245DEFEF9.md) | [clm_4B6461184F69](/claim/clm_4B6461184F69.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 14,462,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_1DE14AF1FBB3](/claim/clm_1DE14AF1FBB3.md) | [clm_702A9C257ED5](/claim/clm_702A9C257ED5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,998,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_C42D4D3906A5](/claim/clm_C42D4D3906A5.md) | [clm_9B48C67E536A](/claim/clm_9B48C67E536A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 13,130,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_A6BEF465151C](/claim/clm_A6BEF465151C.md) | [clm_C708C0B4DD61](/claim/clm_C708C0B4DD61.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,765,867,781 shares | valid 2024-04-25 to 2024-07-29 | conf 0.95 | superseded | superseded_by [clm_EF2804D82FE5](/claim/clm_EF2804D82FE5.md) | [clm_5773E4734F59](/claim/clm_5773E4734F59.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 148,874,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_4B6461184F69](/claim/clm_4B6461184F69.md) | [clm_29497973C1B0](/claim/clm_29497973C1B0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,369,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_1CC594D9C4F0](/claim/clm_1CC594D9C4F0.md) | [clm_5B428B1167B8](/claim/clm_5B428B1167B8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 18,067,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_C708C0B4DD61](/claim/clm_C708C0B4DD61.md) | [clm_5C0E4B389278](/claim/clm_5C0E4B389278.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,798,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_9B48C67E536A](/claim/clm_9B48C67E536A.md) | [clm_854E200D3C92](/claim/clm_854E200D3C92.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 12,310,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_702A9C257ED5](/claim/clm_702A9C257ED5.md) | [clm_E449A119B758](/claim/clm_E449A119B758.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 8,007,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_44F4EB401556](/claim/clm_44F4EB401556.md) | [clm_E994FFA98EDE](/claim/clm_E994FFA98EDE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,766,473,359 shares | valid 2024-01-31 to 2024-04-25 | conf 0.95 | superseded | superseded_by [clm_5773E4734F59](/claim/clm_5773E4734F59.md) | [clm_89944DBAFE9E](/claim/clm_89944DBAFE9E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 12,757,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_7198B453007F](/claim/clm_7198B453007F.md) | [clm_5D66F3208260](/claim/clm_5D66F3208260.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 10,360,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_E994FFA98EDE](/claim/clm_E994FFA98EDE.md) | [clm_897825A51216](/claim/clm_897825A51216.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,863,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_4595D4B200E2](/claim/clm_4595D4B200E2.md) | [clm_89DC93530D47](/claim/clm_89DC93530D47.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | revenue | 54,318,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_46C087CADCC6](/claim/clm_46C087CADCC6.md) | [clm_94FBAE0710ED](/claim/clm_94FBAE0710ED.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 12,814,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_5C0E4B389278](/claim/clm_5C0E4B389278.md) | [clm_D3C029303D23](/claim/clm_D3C029303D23.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 134,711,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_29497973C1B0](/claim/clm_29497973C1B0.md) | [clm_E2D8EC5BAEAA](/claim/clm_E2D8EC5BAEAA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,765,537,421 shares | valid 2023-10-27 to 2024-01-31 | conf 0.95 | superseded | superseded_by [clm_89944DBAFE9E](/claim/clm_89944DBAFE9E.md) | [clm_A6F2CE4E7D05](/claim/clm_A6F2CE4E7D05.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 13,927,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_E449A119B758](/claim/clm_E449A119B758.md) | [clm_2E4438989255](/claim/clm_2E4438989255.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,778,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_5B428B1167B8](/claim/clm_5B428B1167B8.md) | [clm_4ECAA41CE1D4](/claim/clm_4ECAA41CE1D4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 13,287,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_D3C029303D23](/claim/clm_D3C029303D23.md) | [clm_8F4CF168CDB2](/claim/clm_8F4CF168CDB2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 136,221,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_E2D8EC5BAEAA](/claim/clm_E2D8EC5BAEAA.md) | [clm_9AD5695F0536](/claim/clm_9AD5695F0536.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,281,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_854E200D3C92](/claim/clm_854E200D3C92.md) | [clm_A6F43E732D82](/claim/clm_A6F43E732D82.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 12,094,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_897825A51216](/claim/clm_897825A51216.md) | [clm_DA2BBA888E3B](/claim/clm_DA2BBA888E3B.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,765,046,680 shares | valid 2023-07-31 to 2023-10-27 | conf 0.95 | superseded | superseded_by [clm_A6F2CE4E7D05](/claim/clm_A6F2CE4E7D05.md) | [clm_6CE3680212C4](/claim/clm_6CE3680212C4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 135,367,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_9AD5695F0536](/claim/clm_9AD5695F0536.md) | [clm_55D254B2AB25](/claim/clm_55D254B2AB25.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 13,865,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_2E4438989255](/claim/clm_2E4438989255.md) | [clm_593BEB422FF1](/claim/clm_593BEB422FF1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 2,024,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_4ECAA41CE1D4](/claim/clm_4ECAA41CE1D4.md) | [clm_5E66D98A66E7](/claim/clm_5E66D98A66E7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 12,866,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_DA2BBA888E3B](/claim/clm_DA2BBA888E3B.md) | [clm_D0CAEDA52B47](/claim/clm_D0CAEDA52B47.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,759,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_8F4CF168CDB2](/claim/clm_8F4CF168CDB2.md) | [clm_F77382A19536](/claim/clm_F77382A19536.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,513,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_A6F43E732D82](/claim/clm_A6F43E732D82.md) | [clm_FD718C31F784](/claim/clm_FD718C31F784.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,764,289,680 shares | valid 2023-04-25 to 2023-07-31 | conf 0.95 | superseded | superseded_by [clm_6CE3680212C4](/claim/clm_6CE3680212C4.md) | [clm_10DDA59C62B6](/claim/clm_10DDA59C62B6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 134,544,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_55D254B2AB25](/claim/clm_55D254B2AB25.md) | [clm_456ABC3AB1E9](/claim/clm_456ABC3AB1E9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 239,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_5E66D98A66E7](/claim/clm_5E66D98A66E7.md) | [clm_78FB737BE749](/claim/clm_78FB737BE749.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 13,274,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_D0CAEDA52B47](/claim/clm_D0CAEDA52B47.md) | [clm_A6146EA9ECE9](/claim/clm_A6146EA9ECE9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,768,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_FD718C31F784](/claim/clm_FD718C31F784.md) | [clm_C0D9B2A2E414](/claim/clm_C0D9B2A2E414.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 12,225,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_593BEB422FF1](/claim/clm_593BEB422FF1.md) | [clm_CBFCA4B48C56](/claim/clm_CBFCA4B48C56.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,711,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_F77382A19536](/claim/clm_F77382A19536.md) | [clm_D0F44FB1629D](/claim/clm_D0F44FB1629D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,769,399,971 shares | valid 2023-01-31 to 2023-04-25 | conf 0.95 | superseded | superseded_by [clm_10DDA59C62B6](/claim/clm_10DDA59C62B6.md) | [clm_E2538BAC615B](/claim/clm_E2538BAC615B.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 17,254,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_A6146EA9ECE9](/claim/clm_A6146EA9ECE9.md) | [clm_79A5901E7AEB](/claim/clm_79A5901E7AEB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 18,117,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_5D66F3208260](/claim/clm_5D66F3208260.md) | [clm_810E9C4E1BC6](/claim/clm_810E9C4E1BC6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 138,805,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_456ABC3AB1E9](/claim/clm_456ABC3AB1E9.md) | [clm_8F94B2DED299](/claim/clm_8F94B2DED299.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,201,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_D0F44FB1629D](/claim/clm_D0F44FB1629D.md) | [clm_9196480FD2FF](/claim/clm_9196480FD2FF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | revenue | 58,054,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_94FBAE0710ED](/claim/clm_94FBAE0710ED.md) | [clm_C6FBA5E61236](/claim/clm_C6FBA5E61236.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | net_income | 11,836,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_89DC93530D47](/claim/clm_89DC93530D47.md) | [clm_DEF5E95E0C29](/claim/clm_DEF5E95E0C29.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,768,480,508 shares | valid 2022-10-26 to 2023-01-31 | conf 0.95 | superseded | superseded_by [clm_E2538BAC615B](/claim/clm_E2538BAC615B.md) | [clm_056C1FAF9A19](/claim/clm_056C1FAF9A19.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 3,949,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_78FB737BE749](/claim/clm_78FB737BE749.md) | [clm_16B89E250F5D](/claim/clm_16B89E250F5D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 14,812,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_CBFCA4B48C56](/claim/clm_CBFCA4B48C56.md) | [clm_180AA5A76ED5](/claim/clm_180AA5A76ED5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 141,325,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_8F94B2DED299](/claim/clm_8F94B2DED299.md) | [clm_191A92225E47](/claim/clm_191A92225E47.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 11,832,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_9196480FD2FF](/claim/clm_9196480FD2FF.md) | [clm_C88762AEF762](/claim/clm_C88762AEF762.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,603,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_C0D9B2A2E414](/claim/clm_C0D9B2A2E414.md) | [clm_CEA4039DB60E](/claim/clm_CEA4039DB60E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 15,994,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_79A5901E7AEB](/claim/clm_79A5901E7AEB.md) | [clm_D0C776D4C6FD](/claim/clm_D0C776D4C6FD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,768,096,495 shares | valid 2022-07-27 to 2022-10-26 | conf 0.95 | superseded | superseded_by [clm_056C1FAF9A19](/claim/clm_056C1FAF9A19.md) | [clm_20CB053D8AED](/claim/clm_20CB053D8AED.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 143,186,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_191A92225E47](/claim/clm_191A92225E47.md) | [clm_1C492364766C](/claim/clm_1C492364766C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 14,653,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_D0C776D4C6FD](/claim/clm_D0C776D4C6FD.md) | [clm_3DA39727C116](/claim/clm_3DA39727C116.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,295,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_CEA4039DB60E](/claim/clm_CEA4039DB60E.md) | [clm_9573F19B5964](/claim/clm_9573F19B5964.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 924,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_16B89E250F5D](/claim/clm_16B89E250F5D.md) | [clm_D086E009B1C1](/claim/clm_D086E009B1C1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,521,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_C88762AEF762](/claim/clm_C88762AEF762.md) | [clm_D466A4BBCCE0](/claim/clm_D466A4BBCCE0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 14,583,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_180AA5A76ED5](/claim/clm_180AA5A76ED5.md) | [clm_FC05FDDBEA11](/claim/clm_FC05FDDBEA11.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,110,083 shares | valid 2022-04-27 to 2022-07-27 | conf 0.95 | superseded | superseded_by [clm_20CB053D8AED](/claim/clm_20CB053D8AED.md) | [clm_8956DD97BC9C](/claim/clm_8956DD97BC9C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 13,538,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_FC05FDDBEA11](/claim/clm_FC05FDDBEA11.md) | [clm_020CA528788D](/claim/clm_020CA528788D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 4,490,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_D086E009B1C1](/claim/clm_D086E009B1C1.md) | [clm_0A98B6612119](/claim/clm_0A98B6612119.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 16,283,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_3DA39727C116](/claim/clm_3DA39727C116.md) | [clm_55D207F88E40](/claim/clm_55D207F88E40.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,717,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_9573F19B5964](/claim/clm_9573F19B5964.md) | [clm_68DCF1A8E9E3](/claim/clm_68DCF1A8E9E3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 143,211,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_1C492364766C](/claim/clm_1C492364766C.md) | [clm_988B5ED6F448](/claim/clm_988B5ED6F448.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,098,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_D466A4BBCCE0](/claim/clm_D466A4BBCCE0.md) | [clm_C8B5152DE66D](/claim/clm_C8B5152DE66D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,768,753,829 shares | valid 2022-01-31 to 2022-04-27 | conf 0.95 | superseded | superseded_by [clm_8956DD97BC9C](/claim/clm_8956DD97BC9C.md) | [clm_DF17B249782C](/claim/clm_DF17B249782C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 17,924,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_810E9C4E1BC6](/claim/clm_810E9C4E1BC6.md) | [clm_312A48E2B5D0](/claim/clm_312A48E2B5D0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | net_income | 11,542,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_DEF5E95E0C29](/claim/clm_DEF5E95E0C29.md) | [clm_37B2CAD3C6F1](/claim/clm_37B2CAD3C6F1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 146,529,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_988B5ED6F448](/claim/clm_988B5ED6F448.md) | [clm_5711E0284444](/claim/clm_5711E0284444.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,746,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_C8B5152DE66D](/claim/clm_C8B5152DE66D.md) | [clm_A2ED4BA1F89D](/claim/clm_A2ED4BA1F89D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 15,408,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_55D207F88E40](/claim/clm_55D207F88E40.md) | [clm_B2E8F0E008D0](/claim/clm_B2E8F0E008D0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | revenue | 56,197,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_C6FBA5E61236](/claim/clm_C6FBA5E61236.md) | [clm_D102FEEF7A89](/claim/clm_D102FEEF7A89.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,880,465 shares | valid 2021-10-25 to 2022-01-31 | conf 0.95 | superseded | superseded_by [clm_DF17B249782C](/claim/clm_DF17B249782C.md) | [clm_030FB734CC46](/claim/clm_030FB734CC46.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 148,858,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_5711E0284444](/claim/clm_5711E0284444.md) | [clm_40C5FA2D2E2F](/claim/clm_40C5FA2D2E2F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 14,342,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_020CA528788D](/claim/clm_020CA528788D.md) | [clm_7EFD9B1EE312](/claim/clm_7EFD9B1EE312.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 12,182,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_A2ED4BA1F89D](/claim/clm_A2ED4BA1F89D.md) | [clm_90B6D4FB71C7](/claim/clm_90B6D4FB71C7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,306,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_68DCF1A8E9E3](/claim/clm_68DCF1A8E9E3.md) | [clm_A6866F9C10EF](/claim/clm_A6866F9C10EF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 3,179,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_0A98B6612119](/claim/clm_0A98B6612119.md) | [clm_B36E746D71D8](/claim/clm_B36E746D71D8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 13,550,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_B2E8F0E008D0](/claim/clm_B2E8F0E008D0.md) | [clm_B8F0FB3F70F4](/claim/clm_B8F0FB3F70F4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,767,175,532 shares | valid 2021-07-26 to 2021-10-25 | conf 0.95 | superseded | superseded_by [clm_030FB734CC46](/claim/clm_030FB734CC46.md) | [clm_C6A9C2ACDF37](/claim/clm_C6A9C2ACDF37.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 13,959,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_7EFD9B1EE312](/claim/clm_7EFD9B1EE312.md) | [clm_5F5081E18D14](/claim/clm_5F5081E18D14.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,441,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_A6866F9C10EF](/claim/clm_A6866F9C10EF.md) | [clm_76F20660B779](/claim/clm_76F20660B779.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 766,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_B36E746D71D8](/claim/clm_B36E746D71D8.md) | [clm_8C62E1009F26](/claim/clm_8C62E1009F26.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 147,972,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_40C5FA2D2E2F](/claim/clm_40C5FA2D2E2F.md) | [clm_9166925B80EB](/claim/clm_9166925B80EB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,546,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_90B6D4FB71C7](/claim/clm_90B6D4FB71C7.md) | [clm_A85CBBB42CDA](/claim/clm_A85CBBB42CDA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 12,569,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_B8F0FB3F70F4](/claim/clm_B8F0FB3F70F4.md) | [clm_EEA6EF5889A9](/claim/clm_EEA6EF5889A9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,766,222,336 shares | valid 2021-04-28 to 2021-07-26 | conf 0.95 | superseded | superseded_by [clm_C6A9C2ACDF37](/claim/clm_C6A9C2ACDF37.md) | [clm_1D9411A9C895](/claim/clm_1D9411A9C895.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 13,010,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_5F5081E18D14](/claim/clm_5F5081E18D14.md) | [clm_0285E2C1A7E7](/claim/clm_0285E2C1A7E7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 4,103,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_76F20660B779](/claim/clm_76F20660B779.md) | [clm_5F0F6A2FD1C5](/claim/clm_5F0F6A2FD1C5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 3,553,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_8C62E1009F26](/claim/clm_8C62E1009F26.md) | [clm_712B18F8C713](/claim/clm_712B18F8C713.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 13,710,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_EEA6EF5889A9](/claim/clm_EEA6EF5889A9.md) | [clm_875E4AB51928](/claim/clm_875E4AB51928.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,755,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_A85CBBB42CDA](/claim/clm_A85CBBB42CDA.md) | [clm_87EEBCE86395](/claim/clm_87EEBCE86395.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 150,501,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_9166925B80EB](/claim/clm_9166925B80EB.md) | [clm_9715BC353D4D](/claim/clm_9715BC353D4D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,765,881,690 shares | valid 2021-01-31 to 2021-04-28 | conf 0.95 | superseded | superseded_by [clm_1D9411A9C895](/claim/clm_1D9411A9C895.md) | [clm_2867617AC03A](/claim/clm_2867617AC03A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,616,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_37B2CAD3C6F1](/claim/clm_37B2CAD3C6F1.md) | [clm_0EF09B7EC590](/claim/clm_0EF09B7EC590.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 45,804,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_D102FEEF7A89](/claim/clm_D102FEEF7A89.md) | [clm_34A920A5AE6F](/claim/clm_34A920A5AE6F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,449,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_87EEBCE86395](/claim/clm_87EEBCE86395.md) | [clm_386994D20FBA](/claim/clm_386994D20FBA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 150,565,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_9715BC353D4D](/claim/clm_9715BC353D4D.md) | [clm_6E0C0CFE3683](/claim/clm_6E0C0CFE3683.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 11,363,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_312A48E2B5D0](/claim/clm_312A48E2B5D0.md) | [clm_741BF6260BB0](/claim/clm_741BF6260BB0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 13,076,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_875E4AB51928](/claim/clm_875E4AB51928.md) | [clm_B93B782FADFB](/claim/clm_B93B782FADFB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,765,473,923 shares | valid 2020-10-27 to 2021-01-31 | conf 0.95 | superseded | superseded_by [clm_2867617AC03A](/claim/clm_2867617AC03A.md) | [clm_D979467F30C4](/claim/clm_D979467F30C4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 15,270,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_B93B782FADFB](/claim/clm_B93B782FADFB.md) | [clm_30B4D4FDA112](/claim/clm_30B4D4FDA112.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 149,621,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_6E0C0CFE3683](/claim/clm_6E0C0CFE3683.md) | [clm_5B5F473DED16](/claim/clm_5B5F473DED16.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 12,902,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_0285E2C1A7E7](/claim/clm_0285E2C1A7E7.md) | [clm_91BA7A736154](/claim/clm_91BA7A736154.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 2,308,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_712B18F8C713](/claim/clm_712B18F8C713.md) | [clm_AB85F916C6BF](/claim/clm_AB85F916C6BF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,890,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_386994D20FBA](/claim/clm_386994D20FBA.md) | [clm_B9988D4C4506](/claim/clm_B9988D4C4506.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,255,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_5F0F6A2FD1C5](/claim/clm_5F0F6A2FD1C5.md) | [clm_DD94E377758D](/claim/clm_DD94E377758D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000032/0001551152-20-000032-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,764,833,246 shares | valid 2020-07-28 to 2020-10-27 | conf 0.95 | superseded | superseded_by [clm_D979467F30C4](/claim/clm_D979467F30C4.md) | [clm_BBC4CE8C1A41](/claim/clm_BBC4CE8C1A41.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 149,530,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_5B5F473DED16](/claim/clm_5B5F473DED16.md) | [clm_11536613CE39](/claim/clm_11536613CE39.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 10,425,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_91BA7A736154](/claim/clm_91BA7A736154.md) | [clm_1FA32CF37088](/claim/clm_1FA32CF37088.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | -738,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_AB85F916C6BF](/claim/clm_AB85F916C6BF.md) | [clm_22AD188AF61F](/claim/clm_22AD188AF61F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 14,708,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_30B4D4FDA112](/claim/clm_30B4D4FDA112.md) | [clm_A4BBA0E13EE6](/claim/clm_A4BBA0E13EE6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,017,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_B9988D4C4506](/claim/clm_B9988D4C4506.md) | [clm_BBD4856469BA](/claim/clm_BBD4856469BA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 752,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_DD94E377758D](/claim/clm_DD94E377758D.md) | [clm_DDFC85B63FE4](/claim/clm_DDFC85B63FE4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000023/0001551152-20-000023-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,476,742,215 shares | valid 2020-04-30 to 2020-07-28 | conf 0.95 | superseded | superseded_by [clm_BBC4CE8C1A41](/claim/clm_BBC4CE8C1A41.md) | [clm_6FF261038A02](/claim/clm_6FF261038A02.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,603,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_DDFC85B63FE4](/claim/clm_DDFC85B63FE4.md) | [clm_0B42818A10CA](/claim/clm_0B42818A10CA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 41,142,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_BBD4856469BA](/claim/clm_BBD4856469BA.md) | [clm_39876A48A684](/claim/clm_39876A48A684.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -7,415,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_A4BBA0E13EE6](/claim/clm_A4BBA0E13EE6.md) | [clm_4A83CCDD28BD](/claim/clm_4A83CCDD28BD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 91,199,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_11536613CE39](/claim/clm_11536613CE39.md) | [clm_9EF733A037E6](/claim/clm_9EF733A037E6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 8,619,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_1FA32CF37088](/claim/clm_1FA32CF37088.md) | [clm_A47008E5C136](/claim/clm_A47008E5C136.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 3,010,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_22AD188AF61F](/claim/clm_22AD188AF61F.md) | [clm_D228AC43E824](/claim/clm_D228AC43E824.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000015/0001551152-20-000015-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,479,156,683 shares | valid 2020-01-31 to 2020-04-30 | conf 0.95 | superseded | superseded_by [clm_6FF261038A02](/claim/clm_6FF261038A02.md) | [clm_8A7E2D59A0AB](/claim/clm_8A7E2D59A0AB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 89,115,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_9EF733A037E6](/claim/clm_9EF733A037E6.md) | [clm_28B9101888C6](/claim/clm_28B9101888C6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 39,924,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_39876A48A684](/claim/clm_39876A48A684.md) | [clm_80A654D2EDD2](/claim/clm_80A654D2EDD2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 12,983,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_741BF6260BB0](/claim/clm_741BF6260BB0.md) | [clm_CDA568F800DA](/claim/clm_CDA568F800DA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | revenue | 33,266,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_34A920A5AE6F](/claim/clm_34A920A5AE6F.md) | [clm_EB4D7B27A2A8](/claim/clm_EB4D7B27A2A8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -8,172,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_4A83CCDD28BD](/claim/clm_4A83CCDD28BD.md) | [clm_F246E0A322BD](/claim/clm_F246E0A322BD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | net_income | 7,882,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_0EF09B7EC590](/claim/clm_0EF09B7EC590.md) | [clm_FB8073B6F4C9](/claim/clm_FB8073B6F4C9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,478,821,109 shares | valid 2019-10-29 to 2020-01-31 | conf 0.95 | superseded | superseded_by [clm_8A7E2D59A0AB](/claim/clm_8A7E2D59A0AB.md) | [clm_3DCC4BB85B06](/claim/clm_3DCC4BB85B06.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 59,441,000,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_28B9101888C6](/claim/clm_28B9101888C6.md) | [clm_2ADF32E1BBE0](/claim/clm_2ADF32E1BBE0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -8,226,000,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_F246E0A322BD](/claim/clm_F246E0A322BD.md) | [clm_43A1D84452B5](/claim/clm_43A1D84452B5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,884,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_D228AC43E824](/claim/clm_D228AC43E824.md) | [clm_AEBAD82024FE](/claim/clm_AEBAD82024FE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 10,648,000,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_80A654D2EDD2](/claim/clm_80A654D2EDD2.md) | [clm_B886C897B1F0](/claim/clm_B886C897B1F0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 8,479,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_A47008E5C136](/claim/clm_A47008E5C136.md) | [clm_CB0B88225C13](/claim/clm_CB0B88225C13.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,617,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_0B42818A10CA](/claim/clm_0B42818A10CA.md) | [clm_F92C29C59D1E](/claim/clm_F92C29C59D1E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000030/0001551152-19-000030-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,478,483,838 shares | valid 2019-07-29 to 2019-10-29 | conf 0.95 | superseded | superseded_by [clm_3DCC4BB85B06](/claim/clm_3DCC4BB85B06.md) | [clm_0A57708370A6](/claim/clm_0A57708370A6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 57,142,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_2ADF32E1BBE0](/claim/clm_2ADF32E1BBE0.md) | [clm_0931D7B2DE2D](/claim/clm_0931D7B2DE2D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 8,255,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_CB0B88225C13](/claim/clm_CB0B88225C13.md) | [clm_13C8A0924EB0](/claim/clm_13C8A0924EB0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 741,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_AEBAD82024FE](/claim/clm_AEBAD82024FE.md) | [clm_7A765E3288C2](/claim/clm_7A765E3288C2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -8,566,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_43A1D84452B5](/claim/clm_43A1D84452B5.md) | [clm_8B6884305CD5](/claim/clm_8B6884305CD5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,172,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_B886C897B1F0](/claim/clm_B886C897B1F0.md) | [clm_CAA6A1B515D0](/claim/clm_CAA6A1B515D0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,400,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_F92C29C59D1E](/claim/clm_F92C29C59D1E.md) | [clm_CE5BF9768804](/claim/clm_CE5BF9768804.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000023/0001551152-19-000023-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,478,332,177 shares | valid 2019-04-26 to 2019-07-29 | conf 0.95 | superseded | superseded_by [clm_0A57708370A6](/claim/clm_0A57708370A6.md) | [clm_F4CDCC85C327](/claim/clm_F4CDCC85C327.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -7,826,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_8B6884305CD5](/claim/clm_8B6884305CD5.md) | [clm_1101E4339729](/claim/clm_1101E4339729.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 4,897,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_CAA6A1B515D0](/claim/clm_CAA6A1B515D0.md) | [clm_239801DFD565](/claim/clm_239801DFD565.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,010,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_CE5BF9768804](/claim/clm_CE5BF9768804.md) | [clm_2B983894BFBB](/claim/clm_2B983894BFBB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 7,828,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_13C8A0924EB0](/claim/clm_13C8A0924EB0.md) | [clm_7B8BB25C6DC4](/claim/clm_7B8BB25C6DC4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 56,769,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_0931D7B2DE2D](/claim/clm_0931D7B2DE2D.md) | [clm_9CD1CE44F2FC](/claim/clm_9CD1CE44F2FC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 2,456,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_7A765E3288C2](/claim/clm_7A765E3288C2.md) | [clm_A19F5E6ED2F1](/claim/clm_A19F5E6ED2F1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000016/0001551152-19-000016-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,475,083,514 shares | valid 2019-02-08 to 2019-04-26 | conf 0.95 | superseded | superseded_by [clm_F4CDCC85C327](/claim/clm_F4CDCC85C327.md) | [clm_29853AC1B7D4](/claim/clm_29853AC1B7D4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 59,352,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_9CD1CE44F2FC](/claim/clm_9CD1CE44F2FC.md) | [clm_50581791F51E](/claim/clm_50581791F51E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 32,753,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_EB4D7B27A2A8](/claim/clm_EB4D7B27A2A8.md) | [clm_67CC49EA52CC](/claim/clm_67CC49EA52CC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -8,446,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_1101E4339729](/claim/clm_1101E4339729.md) | [clm_690948A561DC](/claim/clm_690948A561DC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 6,383,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_CDA568F800DA](/claim/clm_CDA568F800DA.md) | [clm_C605181FAEA0](/claim/clm_C605181FAEA0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,289,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_239801DFD565](/claim/clm_239801DFD565.md) | [clm_CC9157DEB0B1](/claim/clm_CC9157DEB0B1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,687,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_FB8073B6F4C9](/claim/clm_FB8073B6F4C9.md) | [clm_E37E3A79E8BD](/claim/clm_E37E3A79E8BD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,504,216,327 shares | valid 2018-10-31 to 2019-02-08 | conf 0.95 | superseded | superseded_by [clm_29853AC1B7D4](/claim/clm_29853AC1B7D4.md) | [clm_D17ED6882DEF](/claim/clm_D17ED6882DEF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 66,164,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_50581791F51E](/claim/clm_50581791F51E.md) | [clm_0C6201A46264](/claim/clm_0C6201A46264.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 3,159,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_2B983894BFBB](/claim/clm_2B983894BFBB.md) | [clm_3EFA0ADA51B8](/claim/clm_3EFA0ADA51B8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,015,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_CC9157DEB0B1](/claim/clm_CC9157DEB0B1.md) | [clm_8F6D833F6BDE](/claim/clm_8F6D833F6BDE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 2,747,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_A19F5E6ED2F1](/claim/clm_A19F5E6ED2F1.md) | [clm_A401A3579B68](/claim/clm_A401A3579B68.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -2,921,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_690948A561DC](/claim/clm_690948A561DC.md) | [clm_BEB3B81B5726](/claim/clm_BEB3B81B5726.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 8,236,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_7B8BB25C6DC4](/claim/clm_7B8BB25C6DC4.md) | [clm_EF6AEA6051C0](/claim/clm_EF6AEA6051C0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000042/0001551152-18-000042-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,514,272,698 shares | valid 2018-07-31 to 2018-10-31 | conf 0.95 | superseded | superseded_by [clm_D17ED6882DEF](/claim/clm_D17ED6882DEF.md) | [clm_668466D38903](/claim/clm_668466D38903.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 61,641,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_0C6201A46264](/claim/clm_0C6201A46264.md) | [clm_01E4571FB000](/claim/clm_01E4571FB000.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,762,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_3EFA0ADA51B8](/claim/clm_3EFA0ADA51B8.md) | [clm_0756AC49F7F1](/claim/clm_0756AC49F7F1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -3,375,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_BEB3B81B5726](/claim/clm_BEB3B81B5726.md) | [clm_3A571D375C13](/claim/clm_3A571D375C13.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 3,547,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_8F6D833F6BDE](/claim/clm_8F6D833F6BDE.md) | [clm_6E84A216F14F](/claim/clm_6E84A216F14F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,983,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_A401A3579B68](/claim/clm_A401A3579B68.md) | [clm_A3C668A4FA37](/claim/clm_A3C668A4FA37.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 8,278,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_EF6AEA6051C0](/claim/clm_EF6AEA6051C0.md) | [clm_BDC07E3C1093](/claim/clm_BDC07E3C1093.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000032/0001551152-18-000032-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,586,879,451 shares | valid 2018-04-27 to 2018-07-31 | conf 0.95 | superseded | superseded_by [clm_668466D38903](/claim/clm_668466D38903.md) | [clm_63D489D3F6EF](/claim/clm_63D489D3F6EF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,903,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_0756AC49F7F1](/claim/clm_0756AC49F7F1.md) | [clm_2F093617D53B](/claim/clm_2F093617D53B.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,007,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_6E84A216F14F](/claim/clm_6E84A216F14F.md) | [clm_5A3AC951CCFF](/claim/clm_5A3AC951CCFF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 7,934,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_BDC07E3C1093](/claim/clm_BDC07E3C1093.md) | [clm_638ECD9CFFA0](/claim/clm_638ECD9CFFA0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 2,783,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_A3C668A4FA37](/claim/clm_A3C668A4FA37.md) | [clm_A64BC7BE871E](/claim/clm_A64BC7BE871E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 3,553,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_3A571D375C13](/claim/clm_3A571D375C13.md) | [clm_B65D7E4D5C6E](/claim/clm_B65D7E4D5C6E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 69,342,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_01E4571FB000](/claim/clm_01E4571FB000.md) | [clm_F03C8BE56D8F](/claim/clm_F03C8BE56D8F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000025/0001551152-18-000025-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,587,972,655 shares | valid 2018-02-02 to 2018-04-27 | conf 0.95 | superseded | superseded_by [clm_63D489D3F6EF](/claim/clm_63D489D3F6EF.md) | [clm_DA1BB2B2421A](/claim/clm_DA1BB2B2421A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 70,786,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_F03C8BE56D8F](/claim/clm_F03C8BE56D8F.md) | [clm_212B72E3191E](/claim/clm_212B72E3191E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 9,592,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_C605181FAEA0](/claim/clm_C605181FAEA0.md) | [clm_386A79CBE5AB](/claim/clm_386A79CBE5AB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 5,097,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_B65D7E4D5C6E](/claim/clm_B65D7E4D5C6E.md) | [clm_512AA9C989B0](/claim/clm_512AA9C989B0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | revenue | 28,216,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_67CC49EA52CC](/claim/clm_67CC49EA52CC.md) | [clm_9C790281A637](/claim/clm_9C790281A637.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,309,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_E37E3A79E8BD](/claim/clm_E37E3A79E8BD.md) | [clm_C95C497479DE](/claim/clm_C95C497479DE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,303,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_5A3AC951CCFF](/claim/clm_5A3AC951CCFF.md) | [clm_D8002DD7DB3E](/claim/clm_D8002DD7DB3E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,596,429,740 shares | valid 2017-10-24 to 2018-02-02 | conf 0.95 | superseded | superseded_by [clm_DA1BB2B2421A](/claim/clm_DA1BB2B2421A.md) | [clm_91E5B93BAAD8](/claim/clm_91E5B93BAAD8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,631,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_A64BC7BE871E](/claim/clm_A64BC7BE871E.md) | [clm_013E1D0CE6A0](/claim/clm_013E1D0CE6A0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 6,687,000,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_512AA9C989B0](/claim/clm_512AA9C989B0.md) | [clm_4023A402BB1E](/claim/clm_4023A402BB1E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,705,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_2F093617D53B](/claim/clm_2F093617D53B.md) | [clm_5B10BBC2BC51](/claim/clm_5B10BBC2BC51.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 6,995,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_638ECD9CFFA0](/claim/clm_638ECD9CFFA0.md) | [clm_6578B80CE1C3](/claim/clm_6578B80CE1C3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 68,840,000,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_212B72E3191E](/claim/clm_212B72E3191E.md) | [clm_E218878A198F](/claim/clm_E218878A198F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,446,000,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_D8002DD7DB3E](/claim/clm_D8002DD7DB3E.md) | [clm_ED592A963798](/claim/clm_ED592A963798.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000035/0001551152-17-000035-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,594,094,698 shares | valid 2017-07-24 to 2017-10-24 | conf 0.95 | superseded | superseded_by [clm_91E5B93BAAD8](/claim/clm_91E5B93BAAD8.md) | [clm_95C323AFFAFB](/claim/clm_95C323AFFAFB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 6,009,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_4023A402BB1E](/claim/clm_4023A402BB1E.md) | [clm_3CB07593AF7C](/claim/clm_3CB07593AF7C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,674,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_5B10BBC2BC51](/claim/clm_5B10BBC2BC51.md) | [clm_504B0BC83B6A](/claim/clm_504B0BC83B6A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 6,944,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_6578B80CE1C3](/claim/clm_6578B80CE1C3.md) | [clm_57888AB73869](/claim/clm_57888AB73869.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,915,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_013E1D0CE6A0](/claim/clm_013E1D0CE6A0.md) | [clm_5E4C2023B96B](/claim/clm_5E4C2023B96B.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 66,994,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_E218878A198F](/claim/clm_E218878A198F.md) | [clm_B5248F34B0B8](/claim/clm_B5248F34B0B8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,088,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_ED592A963798](/claim/clm_ED592A963798.md) | [clm_F0AF41EB2CBC](/claim/clm_F0AF41EB2CBC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,591,540,513 shares | valid 2017-04-24 to 2017-07-24 | conf 0.95 | superseded | superseded_by [clm_95C323AFFAFB](/claim/clm_95C323AFFAFB.md) | [clm_A12CA3DA4AB9](/claim/clm_A12CA3DA4AB9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,711,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_5E4C2023B96B](/claim/clm_5E4C2023B96B.md) | [clm_17D012C87892](/claim/clm_17D012C87892.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,998,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_3CB07593AF7C](/claim/clm_3CB07593AF7C.md) | [clm_1D4001B02D65](/claim/clm_1D4001B02D65.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,419,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_504B0BC83B6A](/claim/clm_504B0BC83B6A.md) | [clm_7516913F42F9](/claim/clm_7516913F42F9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 6,538,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_57888AB73869](/claim/clm_57888AB73869.md) | [clm_91E1E8F4CFBF](/claim/clm_91E1E8F4CFBF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 4,740,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_F0AF41EB2CBC](/claim/clm_F0AF41EB2CBC.md) | [clm_94C338ACD4BE](/claim/clm_94C338ACD4BE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 65,664,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_B5248F34B0B8](/claim/clm_B5248F34B0B8.md) | [clm_A31DA02730CF](/claim/clm_A31DA02730CF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,593,920,285 shares | valid 2017-01-31 to 2017-04-24 | conf 0.95 | superseded | superseded_by [clm_A12CA3DA4AB9](/claim/clm_A12CA3DA4AB9.md) | [clm_DA54BBD2450C](/claim/clm_DA54BBD2450C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,636,000,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_1D4001B02D65](/claim/clm_1D4001B02D65.md) | [clm_05B8B5516E3C](/claim/clm_05B8B5516E3C.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 66,099,000,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_A31DA02730CF](/claim/clm_A31DA02730CF.md) | [clm_94513531556F](/claim/clm_94513531556F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | revenue | 25,638,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_9C790281A637](/claim/clm_9C790281A637.md) | [clm_B8A18C367510](/claim/clm_B8A18C367510.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,100,000,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_94C338ACD4BE](/claim/clm_94C338ACD4BE.md) | [clm_CFE5A45B27A0](/claim/clm_CFE5A45B27A0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 9,384,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_386A79CBE5AB](/claim/clm_386A79CBE5AB.md) | [clm_D0B092E67442](/claim/clm_D0B092E67442.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,953,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_C95C497479DE](/claim/clm_C95C497479DE.md) | [clm_F05A32E90FA3](/claim/clm_F05A32E90FA3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,625,099,012 shares | valid 2016-10-24 to 2017-01-31 | conf 0.95 | superseded | superseded_by [clm_DA54BBD2450C](/claim/clm_DA54BBD2450C.md) | [clm_026545419A27](/claim/clm_026545419A27.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 6,432,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_91E1E8F4CFBF](/claim/clm_91E1E8F4CFBF.md) | [clm_2A4B013AE0D7](/claim/clm_2A4B013AE0D7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,598,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_17D012C87892](/claim/clm_17D012C87892.md) | [clm_573466154ABF](/claim/clm_573466154ABF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,218,000,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_CFE5A45B27A0](/claim/clm_CFE5A45B27A0.md) | [clm_79527B6A026A](/claim/clm_79527B6A026A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,361,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_7516913F42F9](/claim/clm_7516913F42F9.md) | [clm_B4012167F64D](/claim/clm_B4012167F64D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 66,626,000,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_94513531556F](/claim/clm_94513531556F.md) | [clm_B9C574866001](/claim/clm_B9C574866001.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 6,469,000,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_05B8B5516E3C](/claim/clm_05B8B5516E3C.md) | [clm_C5F4EFA54CAC](/claim/clm_C5F4EFA54CAC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 67,211,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_B9C574866001](/claim/clm_B9C574866001.md) | [clm_10BA5050BC7D](/claim/clm_10BA5050BC7D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916137453/0001104659-16-137453-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,628,542,359 shares | valid 2016-06-30 to 2016-10-24 | conf 0.95 | superseded | superseded_by [clm_026545419A27](/claim/clm_026545419A27.md) | [clm_28EEE079F857](/claim/clm_28EEE079F857.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916137453/0001104659-16-137453-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 5,640,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_C5F4EFA54CAC](/claim/clm_C5F4EFA54CAC.md) | [clm_2ED4D5DFDB0F](/claim/clm_2ED4D5DFDB0F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916137453/0001104659-16-137453-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,327,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_79527B6A026A](/claim/clm_79527B6A026A.md) | [clm_307C886B12A3](/claim/clm_307C886B12A3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916137453/0001104659-16-137453-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,387,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_B4012167F64D](/claim/clm_B4012167F64D.md) | [clm_B8181F382DF3](/claim/clm_B8181F382DF3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916137453/0001104659-16-137453-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 6,452,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_2A4B013AE0D7](/claim/clm_2A4B013AE0D7.md) | [clm_E445263E135D](/claim/clm_E445263E135D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916137453/0001104659-16-137453-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,610,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_573466154ABF](/claim/clm_573466154ABF.md) | [clm_F99B3D3C908F](/claim/clm_F99B3D3C908F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000025/0001551152-17-000025-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,643,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_2ED4D5DFDB0F](/claim/clm_2ED4D5DFDB0F.md) | [clm_1C685783785E](/claim/clm_1C685783785E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,617,358,607 shares | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_28EEE079F857](/claim/clm_28EEE079F857.md) | [clm_3387E7EBA81F](/claim/clm_3387E7EBA81F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 5,958,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_E445263E135D](/claim/clm_E445263E135D.md) | [clm_50CDB8FC3EC3](/claim/clm_50CDB8FC3EC3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,354,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_F99B3D3C908F](/claim/clm_F99B3D3C908F.md) | [clm_55698570AC31](/claim/clm_55698570AC31.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000016/0001551152-17-000016-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,278,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_B8181F382DF3](/claim/clm_B8181F382DF3.md) | [clm_DCD9157C9133](/claim/clm_DCD9157C9133.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 53,720,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_10BA5050BC7D](/claim/clm_10BA5050BC7D.md) | [clm_DCE037E09A9F](/claim/clm_DCE037E09A9F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,556,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_307C886B12A3](/claim/clm_307C886B12A3.md) | [clm_FC08DA3650E9](/claim/clm_FC08DA3650E9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,611,238,226 shares | valid 2016-01-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_3387E7EBA81F](/claim/clm_3387E7EBA81F.md) | [clm_66A3F5820C42](/claim/clm_66A3F5820C42.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 7,537,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_D0B092E67442](/claim/clm_D0B092E67442.md) | [clm_3F2A5C2764AA](/claim/clm_3F2A5C2764AA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 3,945,000,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_1C685783785E](/claim/clm_1C685783785E.md) | [clm_6F4282E76FED](/claim/clm_6F4282E76FED.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | revenue | 22,859,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_B8A18C367510](/claim/clm_B8A18C367510.md) | [clm_778004ECC385](/claim/clm_778004ECC385.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,399,000,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_FC08DA3650E9](/claim/clm_FC08DA3650E9.md) | [clm_78885045199F](/claim/clm_78885045199F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 53,050,000,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_DCE037E09A9F](/claim/clm_DCE037E09A9F.md) | [clm_D36BDE4DBD80](/claim/clm_D36BDE4DBD80.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,144,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_F05A32E90FA3](/claim/clm_F05A32E90FA3.md) | [clm_E3B87E01B082](/claim/clm_E3B87E01B082.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,634,746,917 shares | valid 2015-09-30 to 2016-01-31 | conf 0.95 | superseded | superseded_by [clm_66A3F5820C42](/claim/clm_66A3F5820C42.md) | [clm_3ACFDECAD445](/claim/clm_3ACFDECAD445.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 54,832,000,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_D36BDE4DBD80](/claim/clm_D36BDE4DBD80.md) | [clm_5BFD83100796](/claim/clm_5BFD83100796.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,863,000,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_6F4282E76FED](/claim/clm_6F4282E76FED.md) | [clm_6F0CD2AA2AA9](/claim/clm_6F0CD2AA2AA9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | quarterly_net_income | 1,239,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_55698570AC31](/claim/clm_55698570AC31.md) | [clm_91D5FCA6D338](/claim/clm_91D5FCA6D338.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115216000005/0001551152-16-000005-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 5,944,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_50CDB8FC3EC3](/claim/clm_50CDB8FC3EC3.md) | [clm_9DB567EABED1](/claim/clm_9DB567EABED1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,885,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_DCD9157C9133](/claim/clm_DCD9157C9133.md) | [clm_A3F1416FDC9E](/claim/clm_A3F1416FDC9E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,223,000,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_78885045199F](/claim/clm_78885045199F.md) | [clm_CE1D0788C2C4](/claim/clm_CE1D0788C2C4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,400,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_CE1D0788C2C4](/claim/clm_CE1D0788C2C4.md) | [clm_11F80DB2CE1F](/claim/clm_11F80DB2CE1F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,852,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_A3F1416FDC9E](/claim/clm_A3F1416FDC9E.md) | [clm_20801B67DB71](/claim/clm_20801B67DB71.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 5,504,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_6F0CD2AA2AA9](/claim/clm_6F0CD2AA2AA9.md) | [clm_213580F78FFD](/claim/clm_213580F78FFD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,655,276,338 shares | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_3ACFDECAD445](/claim/clm_3ACFDECAD445.md) | [clm_23EC71200821](/claim/clm_23EC71200821.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 5,475,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_9DB567EABED1](/claim/clm_9DB567EABED1.md) | [clm_C287D4F05535](/claim/clm_C287D4F05535.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 53,855,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_5BFD83100796](/claim/clm_5BFD83100796.md) | [clm_D42809778327](/claim/clm_D42809778327.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,687,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_20801B67DB71](/claim/clm_20801B67DB71.md) | [clm_12DF3E454E71](/claim/clm_12DF3E454E71.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915036257/0001104659-15-036257-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,593,076,097 shares | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_23EC71200821](/claim/clm_23EC71200821.md) | [clm_1A9033C7E5CD](/claim/clm_1A9033C7E5CD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915036257/0001104659-15-036257-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,906,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_11F80DB2CE1F](/claim/clm_11F80DB2CE1F.md) | [clm_B187D122E493](/claim/clm_B187D122E493.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915036257/0001104659-15-036257-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 26,699,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_D42809778327](/claim/clm_D42809778327.md) | [clm_D450CCC758EE](/claim/clm_D450CCC758EE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915036257/0001104659-15-036257-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 5,040,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_C287D4F05535](/claim/clm_C287D4F05535.md) | [clm_EEF0B5482085](/claim/clm_EEF0B5482085.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465916118639/0001104659-16-118639-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 1,377,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_213580F78FFD](/claim/clm_213580F78FFD.md) | [clm_F432E94DBFE8](/claim/clm_F432E94DBFE8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915036257/0001104659-15-036257-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,593,886,909 shares | valid 2015-01-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_1A9033C7E5CD](/claim/clm_1A9033C7E5CD.md) | [clm_7FD76082DBAA](/claim/clm_7FD76082DBAA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 1,742,000,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_F432E94DBFE8](/claim/clm_F432E94DBFE8.md) | [clm_1D6156E5BADB](/claim/clm_1D6156E5BADB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | revenue | 19,960,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_778004ECC385](/claim/clm_778004ECC385.md) | [clm_3A0D33F3133A](/claim/clm_3A0D33F3133A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 3,411,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_3F2A5C2764AA](/claim/clm_3F2A5C2764AA.md) | [clm_5420B85B9EF4](/claim/clm_5420B85B9EF4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | net_income | 1,774,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E3B87E01B082](/claim/clm_E3B87E01B082.md) | [clm_C1C38D8E4FB1](/claim/clm_C1C38D8E4FB1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,348,000,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_B187D122E493](/claim/clm_B187D122E493.md) | [clm_DCCC204D0954](/claim/clm_DCCC204D0954.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 27,547,000,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_D450CCC758EE](/claim/clm_D450CCC758EE.md) | [clm_EB461D77BDD4](/claim/clm_EB461D77BDD4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 28,454,000,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_EB461D77BDD4](/claim/clm_EB461D77BDD4.md) | [clm_1BEC5D77F87E](/claim/clm_1BEC5D77F87E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914078391/0001104659-14-078391-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,645,000,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_1D6156E5BADB](/claim/clm_1D6156E5BADB.md) | [clm_70ABDD4E760D](/claim/clm_70ABDD4E760D.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914078391/0001104659-14-078391-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 960,000,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_12DF3E454E71](/claim/clm_12DF3E454E71.md) | [clm_9A141AD4FB42](/claim/clm_9A141AD4FB42.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914078391/0001104659-14-078391-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 7,719,000,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_DCCC204D0954](/claim/clm_DCCC204D0954.md) | [clm_A6644DA6B8CD](/claim/clm_A6644DA6B8CD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914078391/0001104659-14-078391-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 5,019,000,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_EEF0B5482085](/claim/clm_EEF0B5482085.md) | [clm_A7029DF5DA96](/claim/clm_A7029DF5DA96.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915076607/0001104659-15-076607-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,593,265,381 shares | valid 2014-09-30 to 2015-01-31 | conf 0.95 | superseded | superseded_by [clm_7FD76082DBAA](/claim/clm_7FD76082DBAA.md) | [clm_F79C518E8FAA](/claim/clm_F79C518E8FAA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914078391/0001104659-14-078391-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 29,045,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_1BEC5D77F87E](/claim/clm_1BEC5D77F87E.md) | [clm_42B02BB64DBB](/claim/clm_42B02BB64DBB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914058340/0001104659-14-058340-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,591,699,124 shares | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_F79C518E8FAA](/claim/clm_F79C518E8FAA.md) | [clm_8AD2A24EAFA5](/claim/clm_8AD2A24EAFA5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914058340/0001104659-14-058340-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,086,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_A6644DA6B8CD](/claim/clm_A6644DA6B8CD.md) | [clm_A2860DB7C8A4](/claim/clm_A2860DB7C8A4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914058340/0001104659-14-058340-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,926,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_A7029DF5DA96](/claim/clm_A7029DF5DA96.md) | [clm_DA4F15CF335B](/claim/clm_DA4F15CF335B.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465915057641/0001104659-15-057641-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 5,218,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_70ABDD4E760D](/claim/clm_70ABDD4E760D.md) | [clm_E3CE62EE8803](/claim/clm_E3CE62EE8803.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914058340/0001104659-14-058340-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,515,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_9A141AD4FB42](/claim/clm_9A141AD4FB42.md) | [clm_F8769037DF45](/claim/clm_F8769037DF45.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914058340/0001104659-14-058340-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,140,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_A2860DB7C8A4](/claim/clm_A2860DB7C8A4.md) | [clm_02534370C6B0](/claim/clm_02534370C6B0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914036968/0001104659-14-036968-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,697,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_E3CE62EE8803](/claim/clm_E3CE62EE8803.md) | [clm_18424292F5EF](/claim/clm_18424292F5EF.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914036968/0001104659-14-036968-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,563,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_DA4F15CF335B](/claim/clm_DA4F15CF335B.md) | [clm_3B799E473A52](/claim/clm_3B799E473A52.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914036968/0001104659-14-036968-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,351,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_F8769037DF45](/claim/clm_F8769037DF45.md) | [clm_781C2FB5DFBA](/claim/clm_781C2FB5DFBA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914036968/0001104659-14-036968-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 28,657,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_42B02BB64DBB](/claim/clm_42B02BB64DBB.md) | [clm_97E99E151E53](/claim/clm_97E99E151E53.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914036968/0001104659-14-036968-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,590,066,459 shares | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_8AD2A24EAFA5](/claim/clm_8AD2A24EAFA5.md) | [clm_A4E4164393FB](/claim/clm_A4E4164393FB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465914036968/0001104659-14-036968-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,588,518,764 shares | valid 2014-01-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_A4E4164393FB](/claim/clm_A4E4164393FB.md) | [clm_C2C5ABA39CC8](/claim/clm_C2C5ABA39CC8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 4,492,000,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_18424292F5EF](/claim/clm_18424292F5EF.md) | [clm_0FAC938AA466](/claim/clm_0FAC938AA466.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | revenue | 18,790,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_3A0D33F3133A](/claim/clm_3A0D33F3133A.md) | [clm_10EA1069A66F](/claim/clm_10EA1069A66F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,595,000,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_02534370C6B0](/claim/clm_02534370C6B0.md) | [clm_4FA738BFF268](/claim/clm_4FA738BFF268.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 29,198,000,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_97E99E151E53](/claim/clm_97E99E151E53.md) | [clm_7B4C916FCBA1](/claim/clm_7B4C916FCBA1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 5,664,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_5420B85B9EF4](/claim/clm_5420B85B9EF4.md) | [clm_A9B273E426B3](/claim/clm_A9B273E426B3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,975,000,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_4FA738BFF268](/claim/clm_4FA738BFF268.md) | [clm_3AE3F00A4472](/claim/clm_3AE3F00A4472.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,371,000,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_781C2FB5DFBA](/claim/clm_781C2FB5DFBA.md) | [clm_852AC8B3FCCC](/claim/clm_852AC8B3FCCC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,658,000,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_3B799E473A52](/claim/clm_3B799E473A52.md) | [clm_A061D1ED53C1](/claim/clm_A061D1ED53C1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,590,861,812 shares | valid 2013-09-30 to 2014-01-31 | conf 0.95 | superseded | superseded_by [clm_C2C5ABA39CC8](/claim/clm_C2C5ABA39CC8.md) | [clm_CF64F485A489](/claim/clm_CF64F485A489.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 28,252,000,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_7B4C916FCBA1](/claim/clm_7B4C916FCBA1.md) | [clm_D47B65E8AFA3](/claim/clm_D47B65E8AFA3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 3,577,000,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_0FAC938AA466](/claim/clm_0FAC938AA466.md) | [clm_DC81000AB742](/claim/clm_DC81000AB742.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,743,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_3AE3F00A4472](/claim/clm_3AE3F00A4472.md) | [clm_2DEB42070657](/claim/clm_2DEB42070657.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 3,558,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_DC81000AB742](/claim/clm_DC81000AB742.md) | [clm_4A958341B1C9](/claim/clm_4A958341B1C9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 27,910,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_D47B65E8AFA3](/claim/clm_D47B65E8AFA3.md) | [clm_81724D6111B8](/claim/clm_81724D6111B8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,692,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_A061D1ED53C1](/claim/clm_A061D1ED53C1.md) | [clm_9BDF5524D4D8](/claim/clm_9BDF5524D4D8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,453,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_852AC8B3FCCC](/claim/clm_852AC8B3FCCC.md) | [clm_ABFEE686F09F](/claim/clm_ABFEE686F09F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,585,428,724 shares | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_CF64F485A489](/claim/clm_CF64F485A489.md) | [clm_AC2DD135BFA3](/claim/clm_AC2DD135BFA3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 6,979,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_2DEB42070657](/claim/clm_2DEB42070657.md) | [clm_06BF7AB6F5F9](/claim/clm_06BF7AB6F5F9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | total_equity | 2,957,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_4A958341B1C9](/claim/clm_4A958341B1C9.md) | [clm_30E9608F5809](/claim/clm_30E9608F5809.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,305,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_ABFEE686F09F](/claim/clm_ABFEE686F09F.md) | [clm_69DD4A7597DD](/claim/clm_69DD4A7597DD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,329,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_9BDF5524D4D8](/claim/clm_9BDF5524D4D8.md) | [clm_8FCC99AEFBF3](/claim/clm_8FCC99AEFBF3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 27,169,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_81724D6111B8](/claim/clm_81724D6111B8.md) | [clm_BF8527D581D8](/claim/clm_BF8527D581D8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | shares_outstanding | 1,583,729,114 shares | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_AC2DD135BFA3](/claim/clm_AC2DD135BFA3.md) | [clm_CFC2CCBD26FA](/claim/clm_CFC2CCBD26FA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 5,817,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_A9B273E426B3](/claim/clm_A9B273E426B3.md) | [clm_2E2748C2CF51](/claim/clm_2E2748C2CF51.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | total_equity | -350,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_30E9608F5809](/claim/clm_30E9608F5809.md) | [clm_3D3AD133EF58](/claim/clm_3D3AD133EF58.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | revenue | 18,380,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_10EA1069A66F](/claim/clm_10EA1069A66F.md) | [clm_7D34A43B5B1E](/claim/clm_7D34A43B5B1E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | total_assets | 27,008,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_BF8527D581D8](/claim/clm_BF8527D581D8.md) | [clm_8F8F210CA067](/claim/clm_8F8F210CA067.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 5,901,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_06BF7AB6F5F9](/claim/clm_06BF7AB6F5F9.md) | [clm_D328E96523A5](/claim/clm_D328E96523A5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 2,761,000,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_D328E96523A5](/claim/clm_D328E96523A5.md) | [clm_21E51F4C56F5](/claim/clm_21E51F4C56F5.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,508,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_8FCC99AEFBF3](/claim/clm_8FCC99AEFBF3.md) | [clm_B5C99B331875](/claim/clm_B5C99B331875.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,596,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_69DD4A7597DD](/claim/clm_69DD4A7597DD.md) | [clm_BC38E2A501A2](/claim/clm_BC38E2A501A2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913083686/0001104659-13-083686-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 1,422,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_BC38E2A501A2](/claim/clm_BC38E2A501A2.md) | [clm_0C8082C36A8A](/claim/clm_0C8082C36A8A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 74,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_21E51F4C56F5](/claim/clm_21E51F4C56F5.md) | [clm_8AB294800E36](/claim/clm_8AB294800E36.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,493,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_B5C99B331875](/claim/clm_B5C99B331875.md) | [clm_FEDE06BBE100](/claim/clm_FEDE06BBE100.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913062262/0001104659-13-062262-index.htm - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 978,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_0C8082C36A8A](/claim/clm_0C8082C36A8A.md) | [clm_495312E370FA](/claim/clm_495312E370FA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 41,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_8AB294800E36](/claim/clm_8AB294800E36.md) | [clm_6BE76CD99628](/claim/clm_6BE76CD99628.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | quarterly_revenue | 4,173,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_FEDE06BBE100](/claim/clm_FEDE06BBE100.md) | [clm_F93636EB7531](/claim/clm_F93636EB7531.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000110465913038917/0001104659-13-038917-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 3,620,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_2E2748C2CF51](/claim/clm_2E2748C2CF51.md) | [clm_3C7DE622672F](/claim/clm_3C7DE622672F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 27,000,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_6BE76CD99628](/claim/clm_6BE76CD99628.md) | [clm_5C2DFBA489B1](/claim/clm_5C2DFBA489B1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | revenue | 17,444,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_7D34A43B5B1E](/claim/clm_7D34A43B5B1E.md) | [clm_A43C77B35651](/claim/clm_A43C77B35651.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | cash_and_equivalents | 10,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_5C2DFBA489B1](/claim/clm_5C2DFBA489B1.md) | [clm_A4E25B7E8BD9](/claim/clm_A4E25B7E8BD9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | state_of_incorporation | DE | valid undated to present | conf 0.95 | valid | [clm_50468CC9D02A](/claim/clm_50468CC9D02A.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | sic_industry | Pharmaceutical Preparations (2834) | valid undated to present | conf 0.95 | valid | [clm_60D3FAD20B06](/claim/clm_60D3FAD20B06.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | registrant_name | AbbVie Inc. | valid undated to present | conf 0.95 | valid | [clm_78F47A4D8706](/claim/clm_78F47A4D8706.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | ticker | ABBV | valid undated to present | conf 0.95 | valid | [clm_B87EDEAECF6B](/claim/clm_B87EDEAECF6B.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | listed_on | NYSE | valid undated to present | conf 0.95 | valid | [clm_BBC331549951](/claim/clm_BBC331549951.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | cik | 0001551152 | valid undated to present | conf 0.95 | valid | [clm_CD48BB22552C](/claim/clm_CD48BB22552C.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | fiscal_year_end | 12-31 | valid undated to present | conf 0.95 | valid | [clm_D5837D9B7367](/claim/clm_D5837D9B7367.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 - [AbbVie](/record/abbvie.md) | headquarters | North Chicago | valid undated to present | conf 0.95 | valid | [clm_E74DBC8CCF1E](/claim/clm_E74DBC8CCF1E.md) sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152 --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.